Fc Fusion Therapeutics Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The market for Fc Fusion therapeutics market was estimated to be worth USD 16.6 billion in 2022, and during the course of the projected period, a CAGR of 10.1% is anticipated. Within the larger biopharmaceutical business, the market for FC (fragment crystallizable) fusion therapies is a niche industry. The fc region of an antibody is combined with a therapeutically-potent protein or peptide to create FC fusion proteins. This combination improves the therapeutic proteins' effectiveness and half-life, which makes it a useful treatment strategy for a range of illnesses. The need for biologics, such as Fc fusion therapies, is driven by the rising prevalence of chronic diseases, including cancer, autoimmune disorders, and inflammatory diseases. The creation of safer and more effective FC fusion medicines is being fueled by advances in protein engineering and drug delivery technology. A strong pipeline of FC fusion proteins is possessed by numerous biopharmaceutical companies, indic...